[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,978,367
  • Shares Outstanding, K 107,352
  • Annual Sales, $ 761,410 K
  • Annual Income, $ 99,650 K
  • EBIT $ -8 M
  • EBITDA $ -11 M
  • 60-Month Beta 0.47
  • Price/Sales 13.28
  • Price/Cash Flow 104.34
  • Price/Book 15.85

Options Overview Details

View History
  • Implied Volatility 51.62% (-10.79%)
  • Historical Volatility 81.65%
  • IV Percentile 32%
  • IV Rank 14.58%
  • IV High 138.94% on 12/15/25
  • IV Low 36.71% on 08/28/25
  • Expected Move (DTE 21) 11.49 (9.71%)
  • Put/Call Vol Ratio 0.59
  • Today's Volume 2,830
  • Volume Avg (30-Day) 573
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 27,266
  • Open Int (30-Day) 26,641
  • Expected Range 106.83 to 129.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.31
  • Number of Estimates 3
  • High Estimate $0.34
  • Low Estimate $0.26
  • Prior Year $0.16
  • Growth Rate Est. (year over year) +93.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.88 +39.40%
on 07/13/26
122.21 -3.18%
on 07/30/26
+31.37 (+36.08%)
since 06/30/26
3-Month
46.19 +156.16%
on 05/01/26
122.21 -3.18%
on 07/30/26
+71.80 (+154.34%)
since 04/30/26
52-Week
28.66 +312.84%
on 02/19/26
122.21 -3.18%
on 07/30/26
+48.41 (+69.25%)
since 07/30/25

Most Recent Stories

More News
Stocks Settle Sharply Higher as Microsoft Leads a Surge in Tech Stocks

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +1.66%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +1.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +3.36%. September E-mini...

MSTR : 97.74 (+4.73%)
SNDK : 1,279.96 (+25.99%)
GLXY : 21.52 (+17.85%)
CROX : 123.66 (-7.38%)
TRI : 98.83 (-7.06%)
COIN : 163.58 (+2.18%)
SBUX : 105.85 (+1.64%)
STX : 851.68 (+11.41%)
WDC : 533.04 (+15.37%)
AMD : 485.39 (+13.00%)
^BTCUSD : 63,903.73 (-1.25%)
EME : 802.37 (+19.32%)
Stocks Rally on Stellar Microsoft Earnings and Chip Stock Strength

The S&P 500 Index ($SPX ) (SPY ) today is up +0.86%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.65%. September E-mini S&P futures...

AMAT : 501.77 (+14.97%)
SNDK : 1,279.96 (+25.99%)
INTU : 315.50 (-5.29%)
CROX : 123.66 (-7.38%)
$SOX : 11,302.99 (+8.19%)
TRI : 98.83 (-7.06%)
$IUXX : 28,106.35 (+3.36%)
FICO : 1,139.54 (-17.01%)
ZNU26 : 108-195 (+0.06%)
MSFT : 451.10 (+15.51%)
ESU26 : 7,507.00 (+0.46%)
SBUX : 105.85 (+1.64%)
Stocks Rebound as Microsoft Earnings Ease AI Spending Concerns

The S&P 500 Index ($SPX ) (SPY ) today is up +1.12%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.69%. September E-mini S&P futures...

AMAT : 501.77 (+14.97%)
SNDK : 1,279.96 (+25.99%)
CROX : 123.66 (-7.38%)
$SOX : 11,302.99 (+8.19%)
$IUXX : 28,106.35 (+3.36%)
FICO : 1,139.54 (-17.01%)
ZNU26 : 108-195 (+0.06%)
MSFT : 451.10 (+15.51%)
ESU26 : 7,507.00 (+0.46%)
SBUX : 105.85 (+1.64%)
NCLH : 18.72 (-9.78%)
STX : 851.68 (+11.41%)
Corcept: Q2 Earnings Snapshot

Corcept: Q2 Earnings Snapshot

CORT : 118.32 (+27.29%)
Corcept (NASDAQ:CORT) Reports Bullish Q2 CY2026, Stock Jumps 17.4%

Corcept (NASDAQ:CORT) Reports Bullish Q2 CY2026, Stock Jumps 17.4%

CORT : 118.32 (+27.29%)
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

Revenue of $256.1 million, a 32 percent increase over the same period in 2025 Korlym ® and...

CORT : 118.32 (+27.29%)
Corcept's Korlym Defense Unraveling Just as Relacorilant Pipeline Needs to Deliver

Barchart Research What to Expect from CORT Earnings CORT Generated July 28, 2026 Current Price $94.19 EPS Estimate $$-0.04 Consensus Rating Moderate Buy Average Move 4.65% Corcept's Korlym Defense Unraveling...

CORT : 118.32 (+27.29%)
Corcept (CORT) Q2 Earnings: What To Expect

Corcept (CORT) Q2 Earnings: What To Expect

CORT : 118.32 (+27.29%)
Why Corcept (CORT) Stock Is Down Today

Why Corcept (CORT) Stock Is Down Today

CORT : 118.32 (+27.29%)
Spotting Winners: Corcept (NASDAQ:CORT) And Branded Pharmaceuticals Stocks In Q1

Spotting Winners: Corcept (NASDAQ:CORT) And Branded Pharmaceuticals Stocks In Q1

CORT : 118.32 (+27.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 142.90
2nd Resistance Point 132.55
1st Resistance Point 125.44
Last Price 118.32
1st Support Level 107.98
2nd Support Level 97.63
3rd Support Level 90.52

See More

52-Week High 122.21
Last Price 118.32
Fibonacci 61.8% 86.47
Fibonacci 50% 75.44
Fibonacci 38.2% 64.40
52-Week Low 28.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.